Nostos Genomics
Latest round
- Seed
Last raised
- Feb 2022
Total raised
- $5.7M
Investors
- 5
About Nostos Genomics
Based in Berlin, Germany, and founded in 2018, Nostos Genomics GmbH operates as a healthcare technology firm that provides AI-based genetic analysis solutions. The company was founded by its CTO, Rocío Acuña Hidalgo, and CEO, David Gorgan.86 post-money. Nostos Genomics provides a genetic disease identification technology platform, which is an artificial intelligence-enabled genetic analysis platform that uses machine learning to detect genetic diseases. The company offers AION, a genetic variant interpretation platform that enables clinicians and researchers to submit case data, which includes a VCF file, family members, and patient characteristics, and then AION generates a report that includes the following information: a list of all variants that have been identified in the case, the classification of each variant (pathogenic, benign), and a list of diseases that are associated with each variant.
Who invested in Nostos Genomics
5 investors across 1 round
See all investors in Nostos Genomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Feb 3, 2022
Amount
$5.7M
Investors
Questions about Nostos Genomics
Who invested in Nostos Genomics?
Nostos Genomics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nostos Genomics raised?
Nostos Genomics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nostos Genomics last raise money?
Nostos Genomics's most recent round on record is a Seed, in Feb 2022.
What does Nostos Genomics do?
Based in Berlin, Germany, and founded in 2018, Nostos Genomics GmbH operates as a healthcare technology firm that provides AI-based genetic analysis solutions.
Where is Nostos Genomics headquartered?
Nostos Genomics is headquartered in Berlin, Germany.
Which VCs invest in companies like Nostos Genomics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Nostos Genomics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Nostos Genomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.